相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival (vol 77, pg 141, 2006)
S Jarvela et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis
JA Haapasalo et al.
CLINICAL CANCER RESEARCH (2006)
Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase
M Hilvo et al.
BIOCHEMICAL JOURNAL (2005)
Carbonic anhydrase inhibitors:: Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides
A Innocenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Expression of hypoxia-inducible carbonic anhydrases in brain tumors
MA Proescholdt et al.
NEURO-ONCOLOGY (2005)
Reduced expression of hypoxia-inducible factor-1α in perinecrotic regions of solid tumors
S Sobhanifar et al.
CANCER RESEARCH (2005)
Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells
D Vordermark et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX
S Pastorekova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX
F Abbate et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion
N Robertson et al.
CANCER RESEARCH (2004)
Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
S Pastorekova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications
P Birner et al.
CLINICAL CANCER RESEARCH (2004)
Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma
A Chrastina et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Superoxide dismutases in the lung and human lung diseases
VL Kinnula et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology
G Reifenberger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin
E Svastova et al.
EXPERIMENTAL CELL RESEARCH (2003)
OLIG-1 and 2 gene expression and oligodendroglial tumours
K Hoang-Xuan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomarker for biliary tumours
J Saarnio et al.
JOURNAL OF HEPATOLOGY (2001)
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
K Hoang-Xuan et al.
NEUROLOGY (2001)
Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors:: A study by novel tumor microarray technique
HE Miettinen et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Expression of the transemembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts
P Karhumaa et al.
MOLECULAR HUMAN REPRODUCTION (2001)
Expression of hypoxia-lnducible cell-surface transmembrane carbonic anhydrases in human cancer
S Ivanov et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
